05/28/2026
Advancing new treatments for childhood cancer and serious blood disorders often starts with access to high-quality biospecimens. ๐ง๐ต๐ฒ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ง๐ถ๐๐๐๐ฒ ๐ฆ๐๐ฝ๐ฝ๐ผ๐ฟ๐ ๐ฆ๐ฒ๐ฟ๐๐ถ๐ฐ๐ฒ (๐ฅ๐ง๐ฆ๐ฆ) provides these critical samples, along with expert research support, to help move these discoveries forward. ๐งฌ
Led by Director ๐๐ฎ๐ฟ๐น ๐๐น๐น๐ฒ๐ป, ๐ ๐, ๐ฃ๐ต๐, and Laboratory Director ๐๐น๐ฒ๐๐๐ฎ๐ป๐ฑ๐ฟ๐ผ ๐๐ฎ๐น๐ฑ๐ฎ๐ป, ๐ฃ๐ต๐, the RTSS is the largest biorepository at Texas Childrenโs Hospital and a central driver of discovery within our Center. The lab stores and distributes biological materials such as tissue and plasma, supporting a wide range of research efforts.
These carefully managed resources enable investigators to identify and validate new treatments and move discoveries closer to clinical application. In addition to providing high-quality specimens, the RTSS offers dedicated research support through technical consultation and shared lab resources, helping teams design and carry out studies effectively.
The RTSS serves as the official biorepository for the Dan L Duncan Comprehensive Cancer Center. The team supports investigators across the Texas Medical Center, as well as national and international partnerships. Each collaboration contributes to a shared mission: improving outcomes and expanding possibilities for children and families.
๐ Explore how RTSS is accelerating nextโgeneration therapies: https://www.texaschildrens.org/tcri/our-research/find-laboratory/research-tissue-support-service-rtss
โน๏ธ๐ฅ Texas Children's Hospital and UT MD Anderson Cancer Center are joining forces to launch the Kinder Children's Cancer Center. Learn more: kinderchildrenscancercenter.org